ICI-Based Urologic Cancer Therapies Tied to High Adverse Event Rates
Urologic cancer treatments based on immune checkpoint inhibitors are associated with a high incidence of treatment- and immune-related adverse events.
Mingmin Li Naval Medical University Clinical School Of Medical College Jinling Hospital Clinical School Medical College
Source: empr.com